Global Interventional Radiology Product Market Analysis – Size, Share & Forecast 2024-2034

Interventional Radiology Product Market Outlook from 2024 to 2034

The interventional radiology product market is projected to reach USD 23.9 billion in 2024. The interventional radiology product are projected to expand at a CAGR of 7.4% from 2024 to 2034. The global interventional radiology product market is expected to reach USD 48.8 billion by 2034.

Attributes	Key Insights
Estimated Market Size in 2024	USD 23.9 billion
Projected Market Value in 2034	USD 48.8 billion
Value-based CAGR from 2024 to 2034	7.4%

Key Market Trends and Highlights

• Medical devices, including digital health technologies, are increasingly integrated into healthcare.
• Remote patient monitoring devices have become popular as preventive care and chronic conditions are managed more efficiently.
• With the advancement of genomics and molecular diagnostics, personalized medicine has become increasingly important.
• Consumers are becoming increasingly interested in wearing devices that monitor their health.
• As healthcare systems and providers integrate, their connections become stronger.

2019 to 2023 Historical Analysis vs. 2024 to 2034 Market Forecast Projections

The interventional radiology product market accounted for a 9% CAGR from 2019 to 2023. A growing focus on improving medical facilities may result in growth in the interventional radiology market in emerging markets. Equipment and product used in interventional radiology may be in higher demand.

Regulatory and healthcare policy changes can have an impact on the market. Stringent regulatory approvals can slow the introduction of new product, while manufacturers can gain an advantage by implementing favorable regulations.

The prevalence of chronic diseases, such as cardiovascular diseases and cancer, often drives the demand for interventional radiology procedures and related product. These conditions will become more common with an aging population, contributing to market growth. A CAGR of 7.4 % is forecast between 2024 and 2034.

Historical CAGR from 2019 to 2023	9%
Forecast CAGR from 2024 to 2034	7.4%

Interventional Radiology Product Drivers

• Individualized treatment plans and diagnostic methods based on patient characteristics are becoming increasingly popular as medical devices advance.
• Medical specialties, including interventional radiology, are increasingly using minimally invasive procedures.
• Product that assist in less invasive procedures with faster recovery times are likely in higher demand as patients and healthcare providers demand faster recovery times.
• Increasing awareness among healthcare professionals and patients can increase the demand for interventional radiology procedures.
• A favorable reimbursement policy can help interventional radiology product and procedures get adopted.

Interventional Radiology Product Challenges

• Manufacturers of medical devices face a challenging regulatory landscape, with numerous international standards and regulations to comply with.
• Advances in interventional radiology can be costly regarding research, development, and testing. Despite lengthy and resource-intensive regulatory approval processes, manufacturers must balance innovation with cost-effectiveness.
• As technology advances rapidly in interventional radiology, product development becomes more complex. Ensuring user-friendliness, interoperability, and connectivity with existing infrastructures is a constant challenge.
• Cybersecurity threats are becoming more common with the increasing integration of interventional radiology product with digital systems. Keeping patient data safe and making medical devices work securely are crucial challenges.
• Healthcare professionals must continue to learn and train about new interventional radiology technologies. Providing practitioners with a thorough understanding of the latest product and techniques can be difficult.

Country-wise Analysis

The section analyzes the interventional radiology product market across key countries, including the United States, United Kingdom, China, Japan, and South Korea. The analysis delves into the specific factors driving the demand for interventional radiology product in these countries.

Countries	Forecast CAGRs from 2024 to 2034
The United States	7.7%
The United Kingdom	6%
China	8.3%
Japan	6.6%
South Korea	5%

Interventional Radiology Product Market in the United States

The United States is expected to expand at a CAGR of 7.7% between 2024 and 2034. Continuous technological advancements drive the demand for interventional radiology product in the United States. Interventional radiology product manufacturers in the United States are quickly adopting new and innovative technologies to improve patient outcomes.

The United States is one of the countries with the highest healthcare expenditures in the world. Due to their financial strength, healthcare facilities can invest in the latest interventional radiology equipment and procedures. In the United States, interventional radiology products are in high demand because chronic conditions like cardiovascular disease and cancer are prevalent. Regulatory environments strictly enforces safety and efficacy standards, widening sales prospects.

Interventional Radiology Product Market in the United Kingdom

• The United Kingdom will experience a 6% CAGR between 2024 and 2034.
• Health systems are crucial in adopting and implementing interventional radiology product in the United Kingdom.
• A rise in cardiovascular disease incidence in the United Kingdom contributes to the demand for interventional radiology product.
• Minimally invasive procedures have become increasingly popular in the United Kingdom.
• Interventional radiology product that reduce patient recovery time are in high demand.
• In the United Kingdom, interventional radiology product are safe and effective due to stringent regulatory frameworks and adherence to quality standards.
• Interventional radiology procedures are becoming more widely known and educated, creating a demand for state-of-the-art equipment.

Interventional Radiology Product Market in China

• China is expected to exhibit a growth rate of 8.3% during the forecast period.
• Increasing healthcare infrastructure has led to growth in interventional radiology product in China to meet growing healthcare needs.
• The demand for interventional radiology product is influenced by government initiatives to improve accessibility and quality in healthcare.
• Incorporating advanced medical technologies is facilitated by funding and support from government agencies.
• As private healthcare in China grows, medical equipment, such as interventional radiology product, is in high demand.
• Technology transfer agreements and collaborations with international companies help introduce high-tech interventional radiology devices to China.

Interventional Radiology Product Market in Japan

• Japan's advanced healthcare system drives innovation in interventional radiology product.
• Medical devices in Japan are regulated robustly to ensure safety and efficacy.
• Interventional radiology product are more trusted than ever due to the stringent approval process, which drives their popularity in the market.
• Japan is expected to expand at a 6.6% CAGR during the forecast period.
• A wide range of medical insurance coverage in Japan makes medical procedures, including interventional radiology, more affordable.

Interventional Radiology Product Market in South Korea

• Healthcare technology and infrastructure have been significantly invested in South Korea, which has led to an increase in interventional radiology product sales.
• Between 2024 and 2034, South Korea is predicted to expand at a CAGR of 5%.
• Medical tourism has become a major industry in South Korea, bringing patients from surrounding countries.
• Heart-related problems are commonly diagnosed and treated with interventional radiology product due to the prevalence of these conditions.
• Private healthcare and rising disposable incomes in South Korea drive demand for medical technology, including interventional radiology product.
• In South Korea, academic institutions and industry players collaborate to develop and introduce innovative interventional radiology techniques.

Category-wise Insights

This section illustrates the market's leading segment. the stent segment is expected to exhibit a CAGR of 7.2% in 2024. Cardiology is expected to experience a CAGR of 6.9% from 2024 to 2034.

Category	CAGR from 2024 to 2034
Stent	7.2%
Cardiology	6.9%

Increasing Incidence of Heart Disease to Drive Stent Demand

Stents have gained considerable market share as the incidence of heart disease and cancer is on the rise. In addition, the number of angioplasty procedures performed worldwide continues to grow. A CAGR of 7.2% is expected for the stent market from 2024 to 2034.

Increasing patient outcomes and reducing complications also contribute to the demand for stents, as bioresorbable and drug-eluting devices are being developed. Due to the growing popularity of minimally invasive procedures that reduce patient trauma and recovery time, the demand for stents is on the rise.

Minimally Invasive Techniques will Drive Demand for Cardiology Procedures

With the growing geriatric population and the increasing prevalence of cardiovascular diseases (CVD), interventional cardiology devices are in demand. Technological advances have led to significant advances in cardiology, including robotic surgical techniques and advanced imaging. Improvements in diagnostic accuracy and treatment precision aim to improve patient outcomes.

Cardiology is increasingly focused on personalized medicine. Personalized treatment plans are tailored for each individual based on genetic characteristics, lifestyle factors, and medical histories. Optimizing treatment effectiveness and minimizing side effects are the goals of personalized medicine. A CAGR of 6.9% is projected for the market during the forecast period.

Integrated healthcare technologies and telemedicine are gaining traction in cardiology. Using these technologies, cardiovascular health can be monitored remotely, teleconsulted, and managed using mobile applications. Early detection of cardiac conditions can be facilitated, and access to care can be improved.

Competitive Landscape

Partnerships and collaborations between market players, research organizations, and healthcare organizations are common. Through these collaborations, knowledge is shared, technology is transferred, and new product are developed together. Innovation can be accelerated, and interventional radiology demand can be driven by leveraging collective expertise and resources.

Key Market Developments

• In September 2023, GE HealthCare and Mayo Clinic collaborated on research and product development to improve patient care and the delivery of new treatments. Scientists, technology developers, clinicians, and others from Mayo Clinic and GE HealthCare participated in the Strategic Collaboration for Innovation in Medical Imaging and Theranostics.
• In November 2023, Argon Medical Devices, an innovator in interventional radiology, vascular surgery, intervention cardiology, and oncology, announced the Kodiak Dual Port Coaxial Introducer Kit, which allows diagnostic and streamlined insertion of diagnostic and therapeutic devices.

Key Coverage of Interventional Radiology Product Report

• Study on interventional radiology product, Growth Analysis of Interventional Radiology Product Market
• Opportunity Analysis of the Interventional Radiology Product
• interventional radiology product Market Scenario
• China Interventional Radiology Product in the Market
• Competitive Analysis of Top Interventional Radiology Product and Support Companies

Report Scope

Attributes	Details
Estimated Market Size in 2024	USD 23.9 billion
Projected Market Valuation in 2034	USD 48.8 billion
Value-based CAGR 2024 to 2034	7.4%
Forecast Period	2024 to 2034
Historical Data Available for	2019 to 2023
Market Analysis	Value in USD billion
Key Regions Covered	North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; The Middle East and Africa
Key Market Segments Covered	Type, Application, End User, Region
Key Countries Profiled	The United States, Canada, Brazil, Mexico, Germany, United Kingdom, France, Spain, Italy, Poland, Russia, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC countries, South Africa, Israel
Key Companies Profiled	Boston Scientific Corporation; Abbott; Cardinal Health; Cook; Stryker; Braun Melsungen AG; Terumo Corporation; General Electric; Koninklijke Philips N.V.; Carestream Health; ESAOTE SPA; Hitachi. Ltd.; Hologic, Inc.; Shimadzu Corporation; Siemens Healthcare GmbH

Table of Content

• 1. Executive Summary
• 2. Market Overview
• 3. Market Background
• 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
• 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product Type
  • 5.1. Stents
  • 5.2. Catheters
  • 5.3. Inferior Vena Cava (IVC) Filters
  • 5.4. Embolization Devices
  • 5.5. Thrombectomy Systems
  • 5.6. Angioplasty Balloons
  • 5.7. Biopsy Needles
  • 5.8. Hemodynamic Flow Alteration Devices
  • 5.9. Accessories
  • 5.10. Others
• 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
  • 6.1. Cardiology
  • 6.2. Oncology
  • 6.3. Gastroenterology
  • 6.4. Neurology
  • 6.5. Orthopedics
  • 6.6. Urology and Nephrology
  • 6.7. Others
• 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
  • 7.1. Hospitals
  • 7.2. Clinics
  • 7.3. Home Care Settings
• 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
  • 8.1. North America
  • 8.2. Latin America
  • 8.3. Western Europe
  • 8.4. Eastern Europe
  • 8.5. South Asia and Pacific
  • 8.6. East Asia
  • 8.7. Middle East and Africa
• 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 16. Key Countries Market Analysis
• 17. Market Structure Analysis
• 18. Competition Analysis
  • 18.1. Boston Scientific Corporation
  • 18.2. Abbott
  • 18.3. Cardinal Health
  • 18.4. Cook
  • 18.5. Stryker
  • 18.6. Braun Melsungen AG
  • 18.7. Terumo Corporation
  • 18.8. General Electric
  • 18.9. Koninklijke Philips N.V.
  • 18.10. Carestream Health
  • 18.11. ESAOTE SPA
  • 18.12. Hitachi, Ltd.
  • 18.13. Hologic, Inc.
  • 18.14. Shimadzu Corporation
  • 18.15. Siemens Healthcare GmbH
• 19. Assumptions & Acronyms Used
• 20. Research Methodology